Destiny Pharma’s SAB Member Professor Dale Gerding is Keynote Speaker at C. diff. International Conference

Brighton, United Kingdom – 4th November 2021 – Destiny Pharma (AIM: DEST), a clinical stage biotechnology company focused on the development of novel medicines to prevent life threatening infections, today announces that its Scientific Advisory Board Member, Professor Dale Gerding, MD, MACP, FIDSA, FSHEA, will be giving a keynote presentation at the C. diff International Conference & Health EXPO to be held in-person and virtually from 4th – 5th November 2021. Destiny Pharma is a Gold Sponsor of the event.

Prof. Gerding’s presentation titled ‘Adjunctive Therapy for CDI to Prevent Recurrence: What Works and Practical Issues’ will be at 7.20pm – 7.40pm GMT/ 2.20pm – 2.40pm EST on Friday 5th November 2021. Registration for the Conference can be found here.

Read more

By Optimum

For more information about Optimum Strategic Communications, please get in touch

We'd love to hear from you...

GET IN TOUCH